1. Home
  2. Author: Michael Zand

All posts by: Michael Zand

About Michael Zand

Sophie’s Choice for Oncologists: Who Gets New Life-Saving Drug – Newsmax

Continue reading

2017-07-07 NEWS

Newsmax

Sophie’s Choice for Oncologists: Who Gets New Life-Saving Drug
Newsmax
Unlike pills or chemotherapy, the therapy known as CAR–T can’t be stockpiled. Because it’s a bespoke treatment that involves re-engineering a patient’s cells in a specialized lab, the logistics of getting CAR–T to the thousands of Americans who will be …
Novartis AG (ADR) (NYSE:NVS) To Face FDA Panel For Cancer Treatment, Kite Pharma Inc (NASDAQ:KITE) Could …Market Exclusive

all 2 news articles »
Continue reading

2017-07-07 NEWS

Newsmax

Sophie’s Choice for Oncologists: Who Gets New Life-Saving Drug
Newsmax
Unlike pills or chemotherapy, the therapy known as CAR–T can’t be stockpiled. Because it’s a bespoke treatment that involves re-engineering a patient’s cells in a specialized lab, the logistics of getting CAR–T to the thousands of Americans who will be …

and more »
Continue reading

2017-07-07 NEWS

The Advertiser

Brothers Michael and Alex Wood share a stem cell bond at the Stadium Stomp
The Advertiser
Michael has fought cancer three times since being diagnosed in Year 8, the latest bout helped by a stem cell transplant from brother Alex. Michael, 22, of Redwood Park, was diagnosed with the blood cancer Hodgkin’s lymphoma at age 13. After six rounds …
Private clinics’ peddling of unproven stem cell treatments is unsafe and unethicalThe Conversation AU
Diabetes alert: Stem Cell Educator therapy is safe and effective for treatmentHindustan Times
Standardized Stem CellsHuffPost
Guardian (blog) –Business Wire (press release) –eHealth Magazine | Elets
all 18 news articles »
Continue reading

2017-07-07 NEWS

J&J turns its back on Capricor and its failed stem cell tech, taking its money and rep with it
Endpoints News
A little more than three years ago, J&J stepped up with a $12.5 million upfront to rent a front row seat on Capricor Therapeutics’ $CAPR Phase II stem cell study, looking to see if their off-the-shelf approach could mend a damaged heart. At the time …
Continue reading

2017-07-07 NEWS

Medical Xpress

Private clinics’ peddling of unproven stem cell treatments is unsafe and unethical
Medical Xpress
Stem cell science is an area of medical research that continues to offer great promise. But as this week’s paper in Science Translational Medicine highlights, a growing number of clinics around the globe, including in Australia, are exploiting …
Brothers Michael and Alex Wood share a stem cell bond at the Stadium StompThe Advertiser
Standardized Stem CellsHuffPost
Stem cell therapies breaking barriersGuardian (blog)
EurekAlert (press release) –Business Wire (press release) –eHealth Magazine | Elets
all 18 news articles »